BRIE ETF Analysis: MFS Blended Research | NYSE

Foreign Large Blend | NYSE, USA | Market Cap: 388m USD | 12M Return: 19.2% | Charts, Fundamentals & Technical Analysis

International Equity, Common Stocks, Depositary Receipts, Emerging Market Securities
Total Rating 55
Safety 51
Buy Signal 0.04
Foreign Large Blend
Category Rotation: -1.1
AUM: 388M
Avg Turnover: 4.16M
Risk 3d forecast
Volatility18.1%
VaR 5th Pctl3.36%
VaR vs Median3.30%
Reward TTM
Sharpe Ratio1.20
Rel. Str. IBD52.7
Rel. Str. Peer Group57.3
Character TTM
Beta0.941
Beta Downside0.898
Hurst Exponent0.448
Drawdowns 3y
Max DD11.39%
CAGR/Max DD2.42
CAGR/Mean DD12.81

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 0.7 years of data

Jan - -
Feb - -
Mar - -
Apr - -
May - -
Jun - -
Jul - -
Aug - -
Sep - -
Oct - -
Nov - -
Dec - -

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: BRIE MFS Blended Research

The fund invests at least 80% of its net assets in equity securities, including common stocks, depositary receipts, and other ownership interests in companies. Portfolio holdings are concentrated in foreign securities, with meaningful exposure to emerging market issuers in addition to developed international markets.

As an actively managed ETF classified within the Foreign Large Blend category, BRIE applies MFSs blended research approach to international stock selection. ETFs in this segment give investors diversified access to non-U.S. equities through a single exchange-traded security, combining diversified international exposure with intraday trading liquidity.

Headlines to Watch Out For
  • USD strength pressures international equity returns
  • Global tariff escalation weighs on developed market holdings
  • Competition intensifies from low-cost EFA and IEFA rivals
What is the price of BRIE shares?

As of July 28, 2026, the stock is trading at USD 29.82 with a total of 120,405 shares traded. Over the past week, the price has changed by +1.05%, over one month by -1.06%, over three months by +4.01% and over the past year by +19.18%.

Current recommended Stop Loss: 29.20 (which is 2.1% or 1.4 ATR below the current price).

Is BRIE a buy, sell or hold?

MFS Blended Research has no consensus analysts rating.